200 related articles for article (PubMed ID: 30864560)
21. The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University.
Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
Int J Gynecol Cancer; 2001; 11(1):39-48. PubMed ID: 11285032
[TBL] [Abstract][Full Text] [Related]
22. Detection of human papillomaviruses from histologically normal lymph nodes of Japanese cervical cancer patients by nested polymerase chain-reaction assay.
Nawa A; Nishiyama Y; Kikkawa F; Kawai M; Mano H; Goto S; Suganuma N; Tomoda Y; Nakashima N
Int J Cancer; 1993 Apr; 53(6):932-7. PubMed ID: 8386139
[TBL] [Abstract][Full Text] [Related]
23. The role of human papillomavirus DNAs in cervical carcinoma and risk of lymph node metastasis: association with 72-kilodalton metalloproteinase immunostaining.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Menso S; De Nictolis M; Romanini C; Biagini G
Cancer; 1998 Mar; 82(5):886-92. PubMed ID: 9486578
[TBL] [Abstract][Full Text] [Related]
24. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up.
Hernádi Z; Szarka K; Sápy T; Krasznai Z; Veress G; Póka R
BJOG; 2003 Feb; 110(2):205-9. PubMed ID: 12618167
[TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus DNA in tumor-free regional lymph nodes: a potential prognostic marker in cervical carcinoma.
Ikenberg H; Wiegering I; Pfisterer J; Kiechle-Schwarz M; Schmitt B; Sauerbrei W; Pfleiderer A
Cancer J Sci Am; 1996; 2(1):28-34. PubMed ID: 9166495
[TBL] [Abstract][Full Text] [Related]
26. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
Szarka K; Veress G; Juhász A; Kónya J; Sápy T; Soós G; Hernádi Z; Gergely L
Anticancer Res; 2000; 20(3B):2161-7. PubMed ID: 10928171
[TBL] [Abstract][Full Text] [Related]
27. The value of the presence of HPV16 in pelvic lymph nodes of cervical cancer patients.
Kedzia H; Gozdzicka-Józefiak A; Kedzia W; Poreba E
Eur J Gynaecol Oncol; 1995; 16(3):199-202. PubMed ID: 7664767
[TBL] [Abstract][Full Text] [Related]
28. Expression of high-risk HPV DNA and CK19 in pelvic lymph nodes in stage Ia-IIa cervical cancer and their clinical value.
Zhang F; Liu D; Lin B; Hao Y; Zhou D; Qi Y; Zhang S
Oncol Rep; 2012 Jun; 27(6):1801-6. PubMed ID: 22407186
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma.
Pinto AP; Schlecht NF; Pintos J; Kaiano J; Franco EL; Crum CP; Villa LL
Gynecol Oncol; 2004 Mar; 92(3):856-65. PubMed ID: 14984953
[TBL] [Abstract][Full Text] [Related]
30. Correlation p53 expression and human papilloma virus deoxyribonucleic acid with clinical outcome in early uterine cervical carcinoma.
Ikuta A; Saito J; Mizokami T; Nakamoto T; Yasuhara M; Nagata F; Nakajima M; Matsuo I; Yasuda K; Kanzaki H
Cancer Detect Prev; 2005; 29(6):528-36. PubMed ID: 16289387
[TBL] [Abstract][Full Text] [Related]
31. [HPV 16 DNA occurrence in lymph nodes of patients with cervical carcinoma].
Łukaszuk K; Liss J; Gulczyński J; Woźniak I; Emerich J; Wójcikowski C
Ginekol Pol; 2003 Feb; 74(2):87-90. PubMed ID: 12715415
[TBL] [Abstract][Full Text] [Related]
32. [Detection of HPV DNA presence in lymph nodes as predictive factor in cervical carcinoma patients].
Lukaszuk K; Liss J
Wiad Lek; 2007; 60(7-8):365-70. PubMed ID: 18175557
[TBL] [Abstract][Full Text] [Related]
33. HPV and histological status of pelvic lymph node metastases in cervical cancer: a prospective study.
Lukaszuk K; Liss J; Wozniak I; Sliwinski W; Emerich J; Wojcikowski C
J Clin Pathol; 2004 May; 57(5):472-6. PubMed ID: 15113853
[TBL] [Abstract][Full Text] [Related]
34. Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion.
Im SS; Wilczynski SP; Burger RA; Monk BJ
Clin Cancer Res; 2003 Sep; 9(11):4145-50. PubMed ID: 14519638
[TBL] [Abstract][Full Text] [Related]
35. The use of polymerase chain reaction to detect metastatic cancer cells within lymph nodes in stage I cervical carcinoma.
Hording U; Ravn V; Knudsen J; Visfeldt J
Int J Gynecol Pathol; 1995 Oct; 14(4):339-43. PubMed ID: 8598337
[TBL] [Abstract][Full Text] [Related]
36. HPV DNA presence and HPV genotypes as prognostic factors in low-stage squamous cell cervical cancer.
van Bommel PF; van den Brule AJ; Helmerhorst TJ; Gallee MP; Gaarenstroom KN; Walboomers JM; Meijer CJ; Kenemans P
Gynecol Oncol; 1993 Mar; 48(3):333-7. PubMed ID: 8385059
[TBL] [Abstract][Full Text] [Related]
37. Correlation of human papillomavirus 16 and 18 with prognostic factors in invasive cervical neoplasias.
Kónya J; Veress G; Hernádi Z; Soós G; Czeglédy J; Gergely L
J Med Virol; 1995 May; 46(1):1-6. PubMed ID: 7622999
[TBL] [Abstract][Full Text] [Related]
38. Molecular Diagnosis for Nodal Metastasis in Endoscopically Managed Cervical Cancer: The Accuracy of the APTIMA Test to Detect High-risk Human Papillomavirus Messenger RNA in Sentinel Lymph Nodes.
Köhler C; Le X; Dogan NU; Pfiffer T; Schneider A; Marnitz S; Bertolini J; Favero G
J Minim Invasive Gynecol; 2016; 23(5):748-52. PubMed ID: 26976197
[TBL] [Abstract][Full Text] [Related]
39. Relationship between human papillomavirus infection and overexpression of p53 protein in cervical carcinomas and lymph node metastases.
Cavuslu S; Goodlad J; Hobbs C; Connor AM; Raju KS; Best JM; Cason J
J Med Virol; 1997 Oct; 53(2):111-7. PubMed ID: 9334921
[TBL] [Abstract][Full Text] [Related]
40. Human papillomavirus 16 DNA in cervical cancers and in lymph nodes of cervical cancer patients: a diagnostic marker for early metastases?
Fuchs PG; Girardi F; Pfister H
Int J Cancer; 1989 Jan; 43(1):41-4. PubMed ID: 2536006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
